Terms: = Breast cancer AND PRDM1, BLIMP1, 639, ENSG00000057657, MGC118925, PRDI-BF1, MGC118924, MGC118922, RP1-134E15_1, O75626, MGC118923
140719 results:
1. The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.
Roesel I; Froehlich D; Joos S; Valentini J; Mauch H; Martus P
Health Qual Life Outcomes; 2024 May; 22(1):39. PubMed ID: 38764032
[TBL] [Abstract] [Full Text] [Related]
2. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
Sharma R; Yadav V; Jha S; Dighe S; Jain S
Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.
Gnangnon FHR; Parenté A; Aboubakar M; Kiki-Migan Y; Totah T; Gbessi DG; Tonato-Bagnan JA; Laleye A; Preux PM; Denakpo JL; Blanquet V; Houinato DS
BMC Womens Health; 2024 May; 24(1):295. PubMed ID: 38762733
[TBL] [Abstract] [Full Text] [Related]
4. Disparities in quality of life among patients with breast cancer based on surgical methods: a cross-sectional prospective study.
Wang Y; He Y; Wu S; Xie S
Sci Rep; 2024 May; 14(1):11364. PubMed ID: 38762615
[TBL] [Abstract] [Full Text] [Related]
5. A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.
Bounous VE; Cipullo I; D'Alonzo M; Martella S; Franchi D; Villa P; Biglia N; Ferrero A
Gynecol Endocrinol; 2024 Dec; 40(1):2334796. PubMed ID: 38760920
[TBL] [Abstract] [Full Text] [Related]
6. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
[TBL] [Abstract] [Full Text] [Related]
7. Weighted metrics are required when evaluating the performance of prediction models in nested case-control studies.
Rentroia-Pacheco B; Bellomo D; Lakeman IMM; Wakkee M; Hollestein LM; van Klaveren D
BMC Med Res Methodol; 2024 May; 24(1):115. PubMed ID: 38760688
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer.
Gottumukkala SB; Ganesan TS; Palanisamy A
NPJ Syst Biol Appl; 2024 May; 10(1):53. PubMed ID: 38760412
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
10. In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques.
Gondokesumo ME; Rasyak MR
Breast Dis; 2024; 43(1):99-110. PubMed ID: 38758988
[TBL] [Abstract] [Full Text] [Related]
11. PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
Thu YM; Suzawa K; Tomida S; Ochi K; Tsudaka S; Takatsu F; Date K; Matsuda N; Iwata K; Nakata K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
PLoS One; 2024; 19(5):e0300644. PubMed ID: 38758826
[TBL] [Abstract] [Full Text] [Related]
12. A prediction model based on digital breast pathology image information.
Sun G; Cai L; Yan X; Nie W; Liu X; Xu J; Zou X
PLoS One; 2024; 19(5):e0294923. PubMed ID: 38758814
[TBL] [Abstract] [Full Text] [Related]
13. Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.
Rajan KK; Fairhurst K; Birkbeck B; Novintan S; Wilson R; Savović J; Holcombe C; Potter S
BJS Open; 2024 May; 8(3):. PubMed ID: 38758563
[TBL] [Abstract] [Full Text] [Related]
14. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early breast cancer.
Rinder P; Marcille T; Sinel-Boucher P; Cals-Maurette M; Kanoun D; Levy C; Teixeira L; Hornus P; Szeftel D; Heudel PE
JAMA Netw Open; 2024 May; 7(5):e2411909. PubMed ID: 38758553
[TBL] [Abstract] [Full Text] [Related]
15. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic factors for the development of upper limb dysfunctions after breast cancer: the UPLIFT-BC prospective longitudinal cohort study protocol.
De Groef A; Vets N; Devoogdt N; Smeets A; Van Assche D; Emmerzaal J; Dams L; Verbeelen K; Fieuws S; Baets L
BMJ Open; 2024 May; 14(5):e084882. PubMed ID: 38754876
[TBL] [Abstract] [Full Text] [Related]
17. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
18. Interaction of sedentary behaviour and educational level in breast cancer risk.
Pinto-Carbó M; Vanaclocha-Espí M; Ibañez J; Martín-Pozuelo J; Romeo-Cervera P; Nolasco A; Besó-Delgado M; Castán-Cameo S; Salas D; Molina-Barceló A
PLoS One; 2024; 19(5):e0300349. PubMed ID: 38753623
[TBL] [Abstract] [Full Text] [Related]
19. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention.
Aumaitre A; Gagnayre R; Foucaut AM
JMIR Res Protoc; 2024 May; 13():e52274. PubMed ID: 38753415
[TBL] [Abstract] [Full Text] [Related]
20. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
[Next]
